M. Seke

4.4k total citations · 1 hit paper
6 papers, 737 citations indexed

About

M. Seke is a scholar working on Pulmonary and Respiratory Medicine, Hepatology and Oncology. According to data from OpenAlex, M. Seke has authored 6 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Hepatology and 1 paper in Oncology. Recurrent topics in M. Seke's work include Prostate Cancer Diagnosis and Treatment (5 papers), Prostate Cancer Treatment and Research (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). M. Seke is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (5 papers), Prostate Cancer Treatment and Research (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). M. Seke collaborates with scholars based in Sweden, Denmark and Finland. M. Seke's co-authors include Lars Franzén, Camilla Thellenberg‐Karlsson, Claes Ginman, Adalsteinn Gunnlaugsson, Per Nilsson, Jon Kindblom, Anders Widmark, Elisabeth Kjellén, Magnus Lagerlund and L. Beckman and has published in prestigious journals such as The Lancet, The Lancet Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

M. Seke

6 papers receiving 734 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

2019 559 citations Anders Widmark, Adalsteinn Gunnlaugsson et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Seke Sweden	6	622	438	184	75	73	6	737
Kirsten Björnlinger Sweden	4	578 0.9×	427 1.0×	177 1.0×	70 0.9×	57 0.8×	7	684
Andrea Moore United Kingdom	7	832 1.3×	595 1.4×	193 1.0×	93 1.2×	83 1.1×	11	931
Magnus Lagerlund Sweden	7	621 1.0×	457 1.0×	190 1.0×	189 2.5×	136 1.9×	11	849
Maria Grazia Petrongari Italy	13	851 1.4×	620 1.4×	183 1.0×	120 1.6×	67 0.9×	27	973
Eric E. K. Yeoh Australia	11	544 0.9×	348 0.8×	170 0.9×	163 2.2×	141 1.9×	13	720
Alberto Bossi Italy	9	602 1.0×	241 0.6×	195 1.1×	86 1.1×	93 1.3×	12	681
Chakiath Jose New Zealand	7	1.1k 1.8×	765 1.7×	188 1.0×	144 1.9×	69 0.9×	9	1.2k
Peter-Paul van der Toorn Netherlands	8	457 0.7×	368 0.8×	166 0.9×	70 0.9×	61 0.8×	14	634
Mark R Storey United States	6	402 0.6×	357 0.8×	147 0.8×	87 1.2×	71 1.0×	8	525
C Marion United States	5	660 1.1×	560 1.3×	219 1.2×	108 1.4×	36 0.5×	7	798

Countries citing papers authored by M. Seke

Since Specialization

Citations

This map shows the geographic impact of M. Seke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Seke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Seke more than expected).

Fields of papers citing papers by M. Seke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Seke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Seke. The network helps show where M. Seke may publish in the future.

Co-authorship network of co-authors of M. Seke

This figure shows the co-authorship network connecting the top 25 collaborators of M. Seke. A scholar is included among the top collaborators of M. Seke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Seke. M. Seke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Fransson, Per, Per Nilsson, Adalsteinn Gunnlaugsson, et al.. (2021). Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial. The Lancet Oncology. 22(2). 235–245. 93 indexed citations

2.

Widmark, Anders, Adalsteinn Gunnlaugsson, L. Beckman, et al.. (2019). Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial. The Lancet. 394(10196). 385–395. 559 indexed citations breakdown →

3.

Widmark, Anders, Adalsteinn Gunnlaugsson, L. Beckman, et al.. (2018). OC-0599: Ultrahypofractionation for prostate cancer: Outcome from the Scandinavian phase 3 HYPO-RT-PC trial. Radiotherapy and Oncology. 127. S314–S314. 14 indexed citations

4.

Widmark, Anders, Adalsteinn Gunnlaugsson, L. Beckman, et al.. (2016). Extreme Hypofractionation versus Conventionally Fractionated Radiotherapy for Intermediate Risk Prostate Cancer: Early Toxicity Results from the Scandinavian Randomized Phase III Trial “HYPO-RT-PC”. International Journal of Radiation Oncology*Biology*Physics. 96(5). 938–939. 27 indexed citations

5.

Hjälm-Eriksson, Marie, Camilla Thellenberg‐Karlsson, Lennart Åström, et al.. (2012). Toxicity in patients receiving adjuvant docetaxel + hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial. Prostate Cancer and Prostatic Diseases. 15(3). 303–307. 21 indexed citations

6.

Nyman, Jan, Signe Friesland, Andreas Hallqvist, et al.. (2008). How to improve loco-regional control in stages IIIa–b NSCLC?. Lung Cancer. 65(1). 62–67. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact